CTIC - CTI BioPharma Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents36,43927,21844,002128,182
Short Term Investments30,599-13.522
Net Receivables13,6791,2788,456782
Inventory-5501,5252,845
Other Current Assets-16,000--
Total Current Assets82,49246,92455,824134,975
Long Term Investments----
Property Plant and Equipment1,7932,3653,0233,718
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets5,5475,5974,9965,504
Deferred Long Term Asset Charges----
Total Assets89,83254,88663,843144,197
Current Liabilities
Accounts Payable4,4982,5887,22710,584
Short/Current Long Term Debt4,8124447,94937,371
Other Current Liabilities1,5532,3367052,321
Total Current Liabilities23,05519,25840,64672,409
Long Term Debt9,26713,57511,31119,124
Other Liabilities4,5715,9634,1295,251
Deferred Long Term Liability Charges----
Minority Interest-5,755-5,723-5,562-4,618
Negative Goodwill----
Total Liabilities36,89338,79656,08696,784
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock58432,170,3002,157,300
Retained Earnings-2,224,746-2,195,346-2,150,326-2,098,317
Treasury Stock-10,643-6,272-6,655-6,952
Capital Surplus2,294,0252,223,388--
Other Stockholder Equity-10,643-6,272-6,655-6,952
Total Stockholder Equity58,69421,81313,31952,031
Net Tangible Assets58,69421,81313,31952,031